Name: Current Challenges in Cell Therapy for Neurodegenerative Diseases (Volume 166) (International Review of Neurobiology, Volume 166) (en Inglés)
Price: 158740.00 CLP
Availability: InStock
Author: Emma L Lane
ISBN: 9780323989374

portada Current Challenges in Cell Therapy for Neurodegenerative Diseases (Volume 166) (International Review of Neurobiology, Volume 166) (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Emma L Lane

Idioma

Inglés

N° páginas

324

Encuadernación

Tapa Dura

ISBN13

9780323989374

N° edición

Current Challenges in Cell Therapy for Neurodegenerative Diseases (Volume 166) (International Review of Neurobiology, Volume 166) (en Inglés)

Emma L Lane (Autor) · Academic Press · Tapa Dura

Libro Nuevo

$ 158.740

$ 317.470

Ahorras: $ 158.730

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 22 de Agosto y el Miércoles 04 de Septiembre.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Current Challenges in Cell Therapy for Neurodegenerative Diseases (Volume 166) (International Review of Neurobiology, Volume 166) (en Inglés)"

Cell Transplantation and Gene Therapy in Neurodegenerative Disease, Volume 166 in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters written by an international board of authors who cover Challenges in translating a cell therapy to GMP, The challenges in developing a cell therapy for Huntington's disease, Challenges of cell therapies for retinal diseases, Challenges of gene therapy in Huntington's Disease, Technological advances and barriers to gene therapy, Considerations in the development of cell therapy modulation for spinal cord injury treatment, Challenges of developing glial cell therapy for ALS, and more. Other chapters in this comprehensive release include Exploring cell and gene therapy in current animal models of Parkinson's and Huntington's disease, Considerations for the use of biomaterials to support cell therapy in degenerative disease, Neurosurgical challenges/innovations in cell and gene therapy delivery, Neuroimaging: the challenge of harnessing imaging tools to facilitate cell and gene therapy in neurodegenerative diseases/The contribution and challenges for imaging in advanced therapies of movement disorders, Considerations for clinical trial design for novel advanced therapeutics in neurodegenerative disease, and More than a trial participant: The role of the patient in ATMP development and trials for neurodegenerative disease.